• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Vaccine patch maker Vaxess names former Sanofi exec as chief strategy officer

March 22, 2023 By Sean Whooley

Vaxess Technologies MIMIX vaccine patch
[Image from the Vaxess website]
Vaxess Technologies, developer of a shelf-stable vaccine patch, announced today that it named Steve Bende as its new chief strategy officer.

Bende previously served as global head of new products at Sanofi Pasteur. He led international, multifunctional teams at the pharmaceutical giant. That included assessing the commercial viability of potential new products.

Prior to Sanofi, Bende held the role of senior policy advisor for the HHS National Vaccine Program Office. Before that, his roles included president and CEO of Bacilligen, consultant for Science & Policy Strategies and The Livingston Group. He also served as VP of scientific affairs for Generic Pharmaceutical Association and as a researcher and administrator at NIAID.

“Steve brings to Vaxess an unparalleled depth and diversity of expertise in strategy, policy, and product development for pharmaceutical and biotechnology companies,” said Michael Schrader, CEO of Vaxess. “Throughout his career, Steve has shown an ability to help organizations of all sizes — from emerging biotech startups to the world’s largest pharmaceutical companies and government agencies — grow and succeed. We’re absolutely thrilled to have him join the Vaxess team as we move our vaccine patches towards commercialization.”

About Vaxess Technologies

Cambridge, Massachusetts-based Vaxess develops a shelf-stable vaccine patch with the potential for self-application.

MiMix features sustained-release technology for administering vaccines and therapeutics. For vaccines, its controlled release simulates the pace of a natural infection. The company said this helps the body produce a slow, strong and enduring immune response ramp. Because it doesn’t require refrigeration, it can be shipped to and applied in low-resource settings, too.

In December 2022, the company reported positive interim results from a first-in-human trial of its influenza vaccine patch. Vaxess also raised $37 million in a Series B trial within the last year. It also grew its team by more than 30%. The team operates at its corporate headquarters in Cambridge and its GMP manufacturing facility in Woburn, Massachusetts.

“The Vaxess team has developed a sustained release patch technology that has the potential to fundamentally change how numerous therapeutics are distributed and administered,” said Bende. “As chief strategy officer, I look forward to working with the company on exploring the many potential applications for this technology, and bringing Vaxess’s first patches to market in the coming years.”

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Personnel, Pharmaceuticals Tagged With: Personnel Moves, Vaxess Technologies

IN CASE YOU MISSED IT

  • Breakthrough T1D, Mattel debut Barbie doll with type 1 diabetes
  • Medtronic Diabetes names CFO with consumer experience ahead of separation
  • Diabeloop launches insulin delivery algorithm in Germany
  • GlucoModicum has positive data for needle-free CGM
  • Lifecare takes next steps in CGM implant development

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS